Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.
Ciuleanu T, Brodowicz T, Zielinski C, Kim JH, Krzakowski M, Laack E, Wu YL, Bover I, Begbie S, Tzekova V, Cucevic B, Pereira JR, Yang SH, Madhavan J, Sugarman KP, Peterson P, John WJ, Krejcy K, Belani CP. Ciuleanu T, et al. Among authors: krejcy k. Lancet. 2009 Oct 24;374(9699):1432-40. doi: 10.1016/S0140-6736(09)61497-5. Epub 2009 Sep 18. Lancet. 2009. PMID: 19767093 Clinical Trial.
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer.
Grønberg BH, Ciuleanu T, Fløtten Ø, Knuuttila A, Abel E, Langer SW, Krejcy K, Liepa AM, Munoz M, Hahka-Kemppinen M, Sundstrøm S. Grønberg BH, et al. Among authors: krejcy k. Lung Cancer. 2012 Oct;78(1):63-9. doi: 10.1016/j.lungcan.2012.07.007. Epub 2012 Aug 20. Lung Cancer. 2012. PMID: 22917813 Clinical Trial.
Phase II trial of gemcitabine in advanced non-small-cell lung cancer.
Malayeri R, Ulsperger E, Baumgartner G, Forstner B, Aigner K, Hubner M, Kummer F, Krajnik G, Zöchbauer S, Krejcy K, Huber H, Pirker R. Malayeri R, et al. Among authors: krejcy k. Wien Klin Wochenschr. 1997 Sep 19;109(17):688-91. Wien Klin Wochenschr. 1997. PMID: 9331958 Clinical Trial.
A phase II multicenter study of two different dosages of pemetrexed given in combination with cyclophosphamide as first-line treatment in patients with locally advanced or metastatic breast cancer.
Dittrich C, Solska E, Manikhas A, Eniu A, Tjulandin S, Anghel R, Musib L, Frimodt-Moller B, Liu Y, Krejcy K, Láng I. Dittrich C, et al. Among authors: krejcy k. Cancer Invest. 2012 May;30(4):309-16. doi: 10.3109/07357907.2012.658938. Epub 2012 Apr 2. Cancer Invest. 2012. PMID: 22468806 Clinical Trial.
Gemcitabine in non-small cell lung cancer (NSCLC).
Manegold C, Zatloukal P, Krejcy K, Blatter J. Manegold C, et al. Among authors: krejcy k. Invest New Drugs. 2000 Feb;18(1):29-42. doi: 10.1023/a:1006327729228. Invest New Drugs. 2000. PMID: 10830139 Review.
51 results